Morphic Holding, Inc. on September 26, 2023, Praveen P. Tipirneni, M.D., the Company?s Chief Executive Officer and a member of the Company?s board of directors (the ?Board?), is taking a temporary medical leave of absence from his role as Chief Executive Officer. In connection with Dr. Tipirneni?s leave of absence, effective November 1, 2023, the Board has appointed Bruce N. Rogers, Ph.D., the Company?s President, as the Company?s interim principal executive officer until Dr. Tipirneni?s return. Dr. Rogers continues to serve as the Company?s President during this interim period.